none
Conditions
Interventions
None listed
Sponsors
others
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: <Cohort A> 1.Subjects who have given written consent. 2.Japanese males or females aged 50 years or older at the time of informed consent. 3.Subjects who are able to call the study site immediately when they experience at least two of common cold-like symptoms, to collect the specimen by themselves within 6 hours from the time they experience the second symptoms, and to visit the study site on the designated date (within 72 hours from the time they experience the second symptoms). Common cold-like symptoms are: Nasal discharge, nasal congestion, pharyngeal pain, cough, wheezing, sputum, shortness of breath, or body temperature of 37.5 degrees or higher. 4.Subjects who are able to visit the study site within the designated period (3, 6, 9 and 12 months after the consent, and the end visit). When the number of subjects reaches the target, the study will be terminated early. In such a case, the end visit will be performed within 30 days after the termination date, and the three-monthly visits mentioned above will no longer be required. <Cohort B> 1.Subjects who have given written consent. 2.Japanese males or females aged 50 years or older at the time of informed consent. 3.Subjects who have at least two of common cold-like symptoms and are able to visit the study site within 72 hours of the onset of the second symptoms. Common cold-like symptoms are: Nasal discharge, nasal congestion, pharyngeal pain, cough, wheezing, sputum, shortness of breath, or body temperature of 37.5 degrees or higher.
Exclusion criteria
Exclusion criteria: Subjects who are assessed as ineligible for the study by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection sensibility in various specimen collection methods | — |
Countries
Japan
Contacts
Public ContactHidetoshi Furuie
Medical Corporation Heishinkai OPHAC Hospital none
Outcome results
None listed